Department of Cellular Pathology, Translational Oncology Research Centre, Queen Alexandra Hospital, Portsmouth, UK.
Anticancer Drugs. 2012 Jan;23(1):65-9. doi: 10.1097/CAD.0b013e32834b1894.
The tricyclic antidepressants have previously been shown to exert activity against glioma cells in vitro. Initial studies in cell lines suggested that this might extend to melanoma cells. We have therefore conducted a study in primary cell cultures from metastatic cutaneous melanoma deposits using a well established ATP-based tumour chemosensitivity assay to confirm and extend these findings. Two cell lines and eight primary cell cultures from metastatic melanoma deposits were exposed to three tricyclic drugs, amitriptyline, nortriptyline and clomipramine, at concentrations ranging from 200 to 6.25 µmol/l in the ATP-based tumour chemosensitivity assay. All three drugs showed activity, although nortriptyline was more active than clomipramine or amitriptyline in both cell lines and primary cell cultures, with an IC50 of 9, 27 and 33 µmol/l, respectively. Tricyclic agents show activity against melanoma in vitro. This could be related to the lysosomal effects based on their cationic amphiphilic properties, or effects at the mitochondrial membrane.
三环类抗抑郁药以前曾被证明在体外对神经胶质瘤细胞具有活性。细胞系的初步研究表明,这种作用可能扩展到黑色素瘤细胞。因此,我们使用一种成熟的基于 ATP 的肿瘤化疗敏感性测定法,在转移性皮肤黑色素瘤沉积的原代细胞培养物中进行了一项研究,以确认和扩展这些发现。将两种细胞系和 8 种来自转移性黑色素瘤沉积的原代细胞培养物暴露于三种三环类药物,阿米替林、去甲替林和氯米帕明,在基于 ATP 的肿瘤化疗敏感性测定法中浓度范围为 200 至 6.25µmol/l。所有三种药物都显示出活性,尽管去甲替林在细胞系和原代细胞培养物中的活性均高于氯米帕明或阿米替林,IC50 分别为 9、27 和 33µmol/l。三环类药物在体外对黑色素瘤具有活性。这可能与基于其阳离子两亲特性的溶酶体作用或线粒体膜的作用有关。